Operating Lease, Liability of HERON THERAPEUTICS, INC. /DE/ from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Operating Lease, Liability in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • HERON THERAPEUTICS, INC. /DE/ Operating Lease, Liability for the quarter ending 30 Sep 2025 was $780,000, a 79% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $780,000 -$2,991,000 -79% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,539,000 -$2,944,000 -66% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,290,000 -$2,892,000 -56% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $3,037,000 -$2,838,000 -48% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $3,771,000 -$2,765,000 -42% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $4,483,000 -$2,255,000 -33% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $5,182,000 -$2,411,000 -32% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $5,875,000 -$2,318,000 -28% 31 Dec 2023 10-K 12 Mar 2024 2023 FY
Q3 2023 $6,536,000 -$2,235,000 -25% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $6,738,000 -$2,591,000 -28% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $7,593,000 -$2,282,000 -23% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $8,193,000 -$2,220,000 -21% 31 Dec 2022 10-K 29 Mar 2023 2022 FY
Q3 2022 $8,771,000 -$6,697,000 -43% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $9,329,000 -$6,846,000 -42% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $9,875,000 -$6,996,000 -41% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $10,413,000 -$7,145,000 -41% 31 Dec 2021 10-K 28 Feb 2022 2021 FY
Q3 2021 $15,468,000 -$2,742,000 -15% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $16,175,000 -$2,667,000 -14% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $16,871,000 -$2,592,000 -13% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $17,558,000 +$3,390,000 +24% 31 Dec 2020 10-K 24 Feb 2021 2020 FY
Q3 2020 $18,210,000 +$5,706,000 +46% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $18,842,000 +$5,869,000 +45% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $19,463,000 +$5,708,000 +41% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $14,168,000 -$332,000 -2.3% 31 Dec 2019 10-K 02 Mar 2020 2019 FY
Q3 2019 $12,504,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $12,973,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $13,755,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $14,500,000 01 Jan 2019 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.